ADAM8/17 Emerges as a Promising Drug Target in Intrahepatic Cholangiocarcinoma
A new study identifies the enzymes ADAM8 and ADAM17 as causally linked drivers of intrahepatic cholangiocarcinoma and demonstrates that a ...
A new study identifies the enzymes ADAM8 and ADAM17 as causally linked drivers of intrahepatic cholangiocarcinoma and demonstrates that a ...
New mouse research shows intestinal HIF1α is unnecessary for the metabolic gains of bariatric surgery but plays a vital protective ...
A new review in Nature Reviews Cardiology details how hypoxia-inducible factors orchestrate metabolic, adenosine, growth factor and circadian pathways that ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine